Inequalities, especially in health care, breed discontent. We need better ways to continue incentivizing the development of new drugs while optimizing access. Biosimilars help, but they won't solve the whole...
ASCO CEO Dr. Clifford Hudis describes the Society's Global Oncology programs and the initiatives of the Global Oncology Leadership Task Force. Dr. Hudis asks challenging questions about providing optimal...
The region has seen structural reforms in health care systems, better training of cancer professionals, new initiatives for populations at high risk, expansion of cancer registries and cancer plans, and...
This is the story of how, like Mr. Smith in Washington, the medical community in Brazil gathered to speak truth to power about the lack of evidence for phosphoethanolamine as a cancer treatment.
Many issues and opportunities require the collective wisdom of the oncology community, but perhaps none are more challenging than those faced by many of our colleagues around the world, as the global burden of...